Global X Financials

GNOM Etf  USD 10.84  0.01  0.09%   
You can harness Global X fundamental data analysis to find out if markets are presently mispricing the etf. We were able to break down and interpolate data for thirty-seven available reported financial drivers for Global X Genomics, which can be compared to its competitors. The etf experiences a normal upward fluctuation. Check odds of Global X to be traded at $11.38 in 90 days. Key indicators impacting Global X's financial strength include:
Net Expense Ratio
0.005
  
The data published in Global X's official financial statements typically reflect Global X's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Global X's quantitative information. For example, before you start analyzing numbers published by Global accountants, it's essential to understand Global X's liquidity, profitability, and earnings quality within the context of the Global X Funds space in which it operates.

Global X Etf Summary

Global X competes with IShares Genomics, Global X, Global X, Global X, and Global X. The fund invests at least 80 percent of its total assets in the securities of the underlying index. Gx Genomics is traded on NASDAQ Exchange in the United States.
InstrumentUSA Etf View All
ExchangeNASDAQ Exchange
ISINUS37954Y4347
CUSIP37954Y434
RegionGlobal
Investment IssuerGlobal X
LocationNew York; U.S.A
Business AddressComplete Genomics, IncMountain
Etf FamilyGlobal X Funds
Fund CategoryStrategy
Portfolio ConcentrationTheme
BenchmarkDow Jones Industrial
Websitewww.completegenomics.com
PhoneNA
CurrencyUSD - US Dollar

Global X Key Financial Ratios

Global Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Global X's current stock value. Our valuation model uses many indicators to compare Global X value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Global X competition to find correlations between indicators driving Global X's intrinsic value. More Info.
Global X Genomics is one of the top ETFs in price to earning as compared to similar ETFs. It also is one of the top ETFs in price to book as compared to similar ETFs . Comparative valuation analysis is a catch-all technique that is used if you cannot value Global X by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Global X Genomics Systematic Risk

Global X's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Global X volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Global X Genomics correlated with the market. If Beta is less than 0 Global X generally moves in the opposite direction as compared to the market. If Global X Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Global X Genomics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Global X is generally in the same direction as the market. If Beta > 1 Global X moves generally in the same direction as, but more than the movement of the benchmark.

Global X Thematic Clasifications

Global X Genomics is part of several thematic ideas from Strategy ETFs to Theme ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas

Global X December 1, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Global X help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Global X Genomics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Global X Genomics based on widely used predictive technical indicators. In general, we focus on analyzing Global Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Global X's daily price indicators and compare them against related drivers.
When determining whether Global X Genomics is a strong investment it is important to analyze Global X's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global X's future performance. For an informed investment choice regarding Global Etf, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global X Genomics. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
The market value of Global X Genomics is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global X's value that differs from its market value or its book value, called intrinsic value, which is Global X's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global X's market value can be influenced by many factors that don't directly affect Global X's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global X's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global X is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global X's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.